Scynexis (SCYX) Interest Expenses (2013 - 2026)
Scynexis (SCYX) posted Interest Expenses of $25000.0 for Q1 2026, up 110.12% on a QoQ basis from -$247000.0 in Q4 2025, and down 94.05% year-over-year from $420000.0 in Q1 2025.
Scynexis (SCYX) Interest Expenses (2013 - 2026) Analysis & Trends
Scynexis' Interest Expenses history runs 14 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- Quarterly Interest Expenses fell 94.05% year-over-year to $25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25000.0 (down 98.04% YoY) and the FY2025 annual result came in at $744000.0, down 98.92% from the prior year.
- Interest Expenses was $25000.0 for Q1 2026 at Scynexis, up from -$247000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $2.6 million in Q4 2023 and bottomed at -$2.8 million in Q4 2022.
- A 5-year average of $497250.0 and a median of $337000.0 in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses slumped 354.9% — and 2023, when it surged 193.35%.
- Scynexis' Interest Expenses stood at -$2.8 million in 2022, then jumped by 193.35% to $2.6 million in 2023, then plunged by 91.41% to $223000.0 in 2024, then slumped by 210.76% to -$247000.0 in 2025, then surged by 110.12% to $25000.0 in 2026.
- Business Quant data shows SCYX's Interest Expenses at $25000.0 in Q1 2026, -$247000.0 in Q4 2025, and $5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | -247,000.00 |
| Dec 31, 2025 | -247,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 420,000.00 |
| Mar 31, 2025 | 420,000.00 |
| Dec 31, 2024 | 223,000.00 |
| Dec 31, 2024 | 223,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 420,000.00 |
| Mar 31, 2024 | 420,000.00 |
| Dec 31, 2023 | 2.60 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 212,000.00 |
| Sep 30, 2023 | 212,000.00 |